首页> 外国专利> opiumalkaloidantigen to anvendning at framstellning of an antibody which can be used in immunoassays of opiumalkaloiden in biological vetska

opiumalkaloidantigen to anvendning at framstellning of an antibody which can be used in immunoassays of opiumalkaloiden in biological vetska

机译:鸦片生物碱抗原,可在抗体的构图上使用,可用于生物维特斯卡生物碱中鸦片生物碱的免疫分析

摘要

1320056 Opium alkaloid antigens and antibodies F HOFFMANN-LA ROCHE & CO AG 13 May 1971 [13 May 1970] 14629/71 Heading A5B [Also in Divisions B1 and C2] An opium alkaloid antigen consisting of a carboxy-C 1-6 alkyl derivative of the phenolic hydroxy group of an opium alkaloid coupled to an immunogenic carrier material is prepared by reacting the opium alkaloid derivative with an immunogenic carrier material. The immunogenic carrier material may be a protein such as human gamma globulin, human serum albumin, rabbit serum albumin, bovine gamma globulin and bovine serum albumin; a natural or synthetic polymeric compound such as a polypeptide e.g. polylysine or a polysaccharide. The opium alkaloid may be morphine, heroin, codeine or nalorphine or a derivative thereof and the preferred carboxyalkyl derivative of an opium alkaloid is 3-O-carboxymethylmorphine. The reaction may be carried out in an aqueous reaction medium having a pH of 3 to 6.5, at 0‹C to 50‹C, using a molar excess of 30 to 10,000 of the opium alkaloid derivative, in the presence of a water-soluble coupling agent such as a carbodiimide e.g. 1-ethyl- 3-(3-dimethylaminopropyl) carbodiimide. An opium alkaloid specific antibody consisting of a gamma globulin fraction protein having a multiplicity of sites which will selectively complex with an opium alkaloid, a carboxyalkyl derivative of the phenolic hydroxy group of an opium alkaloid or an opium alkaloid antigen consisting of a carboxyalkyl derivative of the phenolic hydroxy group of the opium alkaloid coupled to an immunogenic carrier material is prepared by injecting the opium alkaloid antigen into a host animal repeatedly over a period of time until opium alkaloid specific antibody is present in the blood stream, collecting a blood sample from the host animal after the injection period is completed, separating the serium from the blood sample, precipitating the antibodies from the serum by treating the serum with a neutral salt solution e.g. ammonium sulphate and purifying the antibodies.
机译:1320056鸦片生物碱抗原和抗体F HOFFMANN-LA ROCHE&CO AG 1971年5月13日[1970年5月13日] 14629/71标题A5B [B1和C2处也有鸦片]由羧基C 1-6烷基衍生物组成的鸦片生物碱抗原通过使鸦片生物碱衍生物与免疫原性载体材料反应来制备与免疫原性载体材料偶联的鸦片生物碱的酚羟基的氨基。免疫原性载体材料可以是蛋白质,例如人γ球蛋白,人血清白蛋白,兔血清白蛋白,牛γ球蛋白和牛血清白蛋白;等等。天然或合成的聚合化合物,例如多肽,例如聚赖氨酸或多糖。鸦片生物碱可以是吗啡,海洛因,可待因或纳洛啡或其衍生物,并且鸦片生物碱的优选的羧基烷基衍生物是3-O-羧甲基吗啡。该反应可以在pH为3至6.5的水性反应介质中,在0℃至50℃下,使用30至10,000摩尔过量的鸦片生物碱衍生物,在水溶性存在下进行。偶合剂,例如碳二亚胺,例如1-乙基-3-(3-二甲基氨基丙基)碳二亚胺。鸦片生物碱特异性抗体,由具有多个位点的γ球蛋白级分蛋白组成,可以选择性地与鸦片生物碱,鸦片生物碱酚羟基的羧基烷基衍生物或鸦片生物碱抗原(由鸦片生物碱的酚羟基与免疫原性载体材料偶联,是通过在一段时间内反复将鸦片生物碱抗原注入宿主动物中直至鸦片生物碱特异性抗体存在于血流中,并从宿主收集血液样品来制备注射期结束后,将动物与血清分离,通过用中性盐溶液处理血清,从血清中沉淀出抗体硫酸铵并纯化抗体。

著录项

  • 公开/公告号SE417970B

    专利类型

  • 公开/公告日1981-04-27

    原文格式PDF

  • 申请/专利权人 F * HOFFMANN-LA ROCHE & CO AG;

    申请/专利号SE19740008140

  • 发明设计人 S * SPECTOR;

    申请日1974-06-19

  • 分类号C07G7/00;G01N33/94;

  • 国家 SE

  • 入库时间 2022-08-22 16:01:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号